Skip to main content
Ellen Ritchie, MD, Hematology, New York, NY, New York-Presbyterian Hospital

EllenKellyRitchieMD

Hematology • New York, NY

Hematologic Oncology

Associate Clinical Professor of Medicine, Weill Cornell Medical College

Request Appointment

Overview of Dr. Ritchie

Dr. Ellen Ritchie is a malignant hematologist in New York, NY and is affiliated with Weill Cornell Medicine-New York Presbyterian Hospital in NYC. She received her medical degree from Columbia University Vagelos College of Physicians and Surgeons and has been in practice 20 years. She specializes in hematologic oncology and is experienced in leukemia, MDS, MPNs. She has more than 100 publications and over 500 citings.

Education & Training

  • New York Presbyterian Hospital (Cornell Campus)
    New York Presbyterian Hospital (Cornell Campus)Fellowship, Hematology and Medical Oncology, 2000 - 2004
  • New York Presbyterian Hospital (Cornell Campus)
    New York Presbyterian Hospital (Cornell Campus)Residency, Internal Medicine, 1997 - 2000
  • Columbia University Vagelos College of Physicians and Surgeons
    Columbia University Vagelos College of Physicians and SurgeonsClass of 1997

Certifications & Licensure

  • NY State Medical License
    NY State Medical License 1999 - 2026

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011-2013

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Somatic Mutations Precede Acute Myeloid Leukemia Years Before Diagnosis  
    Sangmin Lee, Pinkal Desai, Gail J Roboz, Ellen K Ritchie, Nature

Abstracts/Posters

  • Durable Remission and Long-Term Survival in Relapsed/Refractory (r/r) AML Patients Treated with Guadecitabine, Median Survival Not Reached for Responders after Long Te...
    Ellen K. Ritchie, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
  • Genetic Characteristics and Outcomes By Mutation Status in a Phase 3 Study of CPX-351 Versus 7+3 in Older Adults with Newly Diagnosed, High-Risk/Secondary Acute Myeloi...
    Ellen K. Ritchie, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
  • Outcomes in Patients with Acute Myeloid Leukemia with Myelodysplasia-Related Changes (AML-MRC) Who Achieved Remission with CPX-351 Versus 7+3: Phase 3 Exploratory Anal...
    Ellen K. Ritchie, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
  • Join now to see all

Lectures

  • Patient-Reported Outcomes (PRO) Data from Patients (Pts) with Essential Thrombocythemia (ET) Enrolled in the MOST Study 
    61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
  • CPX-351 As First Intensive Therapy for Elderly Patients with AML 
    61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
  • Outcomes with CPX-351 versus 7+3 by baseline bone marrow (BM) blast percentage in older adults with newly diagnosed high-risk/secondary acute myeloid leukemia (sAML). 
    2019 ASCO Annual Meeting - 6/1/2019
  • Join now to see all

Authored Content

  • Clinical Trial Patient Shortage Will Hinder the Progress of AML Drug DevelopmentDecember 2018

Press Mentions

  • Nobody Wants Cancer. But a ‘Big C’ Label Has Surprising Upsides
    Nobody Wants Cancer. But a ‘Big C’ Label Has Surprising UpsidesMarch 11th, 2021
  • Astellas Presents New Data on XOSPATA® (Gilteritinib) in FLT3 Mutation-Positive Relapsed/Refractory Acute Myeloid Leukemia at the 2019 American Society of Hematology Annual Meeting
    Astellas Presents New Data on XOSPATA® (Gilteritinib) in FLT3 Mutation-Positive Relapsed/Refractory Acute Myeloid Leukemia at the 2019 American Society of Hematology Annual MeetingDecember 2nd, 2019
  • Incyte Supports the Myeloproliferative Neoplasm (MPN) Community During Blood Cancer Awareness Month
    Incyte Supports the Myeloproliferative Neoplasm (MPN) Community During Blood Cancer Awareness MonthSeptember 1st, 2017
  • Join now to see all

Professional Memberships

Hospital Affiliations

Insurance Accepted

  • Aetna Choice POS II
    Aetna HMO
    BCBS Blue Card PPO
    CIGNA HMO
    CIGNA Open Access
    CIGNA PPO
    Coventry Missouri - HMO/POS
    Empire BCBS HMO
    Empire BCBS PPO
    GHI PPO
    Great West PPO
    Healthfirst New York
    HIP of New York - Select PPO
    Humana ChoiceCare Network PPO
    MVP Healthcare PPO
    Oxford Health Freedom
    Oxford Health Liberty
    United Healthcare - Direct Choice Plus POS
    United Healthcare - Direct Options PPO
  • Please verify your coverage with the provider's office directly when scheduling an appointment

Dr. Ellen Ritchie, Dr. Ellen Ritchie, MD, Dr. E Ritchie, Dr. Ellen Kelly Ritchie